Latest news with #AndreasEschbach
Malaysian Reserve
17-07-2025
- Business
- Malaysian Reserve
Shiftconnector Artificial Manufacturing Intelligence by eschbach Wins Platinum Pinnacle Technology Award
AI-Powered Software Transforms Pharma & Chemical Manufacturing for Smarter, Safer Operations. BOSTON, July 17, 2025 /PRNewswire/ — Global software leader eschbach has won the prestigious Platinum Pinnacle Technology Award in the Productivity and Collaboration Tools category. This achievement underscores the revolutionary advancements of their Shiftconnector® platform, particularly the AI-driven Shiftconnector® Artificial Manufacturing Intelligence (SAMI®), which is transforming the process industry. The Pinnacle Technology Award recognizes groundbreaking developments and solutions that push the boundaries of innovation and enhance everyday experiences across industries. This prestigious honor celebrates those who are redefining how we work, connect, and solve problems through transformative technology. In the manufacturing sector, eschbach's Shiftconnector® stands out as a powerful example—enhancing the daily workflows of operators by making critical data more accessible, actionable, and intuitive than ever before. With its latest enhancements, SAMI transforms how pharmaceutical and chemical manufacturing teams interact with operational data. By integrating Generative AI (GenAI) into a conversational interface, SAMI empowers users to ask questions in natural language and receive instant, contextual insights—dramatically improving decision-making speed and accuracy. 'By combining advanced AI with intuitive visualization tools, we've created a seamless way for teams to access and act on critical information,' said Andreas Eschbach, Founder and CEO of eschbach. 'This award validates our commitment to making manufacturing collaboration smarter, faster, and more human-centric.' Kate Lang, Executive Director of the Pinnacle Awards, emphasized eschbach's exceptional contribution: 'This award celebrates excellence in technology and leadership, particularly in how eschbach is redefining information access and problem-solving within manufacturing.' The enhanced SAMI chat feature liberates users from traditional, time-consuming interfaces. Instead of navigating complex reports, employees can simply ask, 'What happened during last night's shift?' and receive a clear, traceable summary of events and actions. Built on the robust capabilities of Smart Search and Smart Solutions, SAMI now delivers even greater precision, speed, and traceability—making it an indispensable tool for high-stakes environments in chemical and pharmaceutical production. About eschbachWith its global headquarters in Bad Säckingen, Germany and its North America headquarters in Boston, MA, eschbach is the premier enterprise software developer for plant process management. Shiftconnector's AI-driven technology helps manufacturing teams take charge of plant operations, process safety, asset performance, and product quality. eschbach serves process industries and supports digital transformation, helping managers, operators, and technicians to achieve the highest level of team communications. The award-winning solution is trusted worldwide by leading manufacturing companies such as DuPont, Albemarle, BASF, Roche, and Bayer. Media Contact – North AmericaDawn FontaineRipple Effect CommunicationsT: 617-536-8887dawn@
Forbes
26-06-2025
- Business
- Forbes
The Pharmaceutical Industry's AI Journey And Digital Transformation
Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture. To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered technologies is not just desirable but essential. Pharma's future hinges on embracing digital transformation and leveraging the power of AI to streamline operations, enhance problem-solving and root cause analysis, drive continuous improvement and mitigate risks within the pharmaceutical regulatory and compliance landscape. The AI-Powered Future Of Pharma AI is projected to generate between $60 billion and $110 billion in annual economic value for the pharmaceutical sector. Such untapped potential stems primarily from AI's ability to improve productivity across the drug lifecycle. Digital tools that can be tailored to complex processes and operational workflows, in addition to being more easily personalized to users' needs, will be key. The pharmaceutical industry is estimated to invest $4.5 billion in its digital transformation initiatives within five years. The main manufacturing focus for digitalization will be on the optimization of operations, increased productivity and enhanced quality. Raw material conversion costs will decrease, and reliability with delivery will improve. However, often due to issues in data quality, costly connectivity and maintenance challenges, as well as regulatory complexities, not all AI initiatives have been able to meet expectations. Success in AI initiatives can't happen without taking into account the needs of the organization's people, nor if the initiatives are not integrated into existing workflows. The most valuable gains from AI will likely result from the empowerment of people and using enhanced data analysis, knowledge management and augmented decision making. The Key To Data Liberation Too often, critical data is siloed across multiple systems that support pharmaceutical manufacturing—whether it be MES, historian or LIMS —and data is buried within unstructured sources like shift notes and maintenance logs. Such data silos cause fragmentation, hindering information transparency and accessibility as well as making it nearly impossible to deliver the right information to the right people at the right time. Manufacturing facilities produce vast quantities of data from both automated sensors and human-generated notes (e.g., shift notes, compliance reports, etc.). However, much of this valuable information remains hidden or difficult to access, leading to inefficiencies and missed opportunities. Employees may spend hours searching through multiple data sources for information relevant to their current problem or task if they are able to find it at all. AI, however, can help to bring buried pharmaceutical operational information to the surface by pulling data from shift notes, maintenance logs and other sources of structured and unstructured data. Utilizing natural language processing and machine learning enables people to ask questions in plain language, delivering the most relevant results in seconds rather than minutes or hours. This dramatically improves efficiency and access to valuable information. Unlocking Historical Knowledge Many manufacturing issues have historical precedents, but the solutions are often hidden in unstructured notes or lost when experienced workers retire or move on. The deep institutional knowledge required for informed root cause analysis and swift problem resolution is often scattered or missing. This leads to delays in problem resolution, as employees must either spend hours searching for relevant information or reinvent the wheel entirely each time a problem is encountered. AI-powered tools can comb through past notes and data to identify historical precedents that can inform current issues. Using that data, it can then suggest potential root causes and present potential solutions for better decision making through AI's ability to run through similar past incidents. Production teams can then quickly get back on track. The technology will link directly to relevant notes and events so employees can see exactly what happened, who was involved, the most likely root cause and the impacts of actions taken. Building A Culture Of Continuous Improvement AI is a powerful driver of continuous improvement (CI) in pharmaceutical manufacturing, enabling teams to proactively identify opportunities for efficiency, quality and performance gains. AI applications can facilitate CI by capturing critical knowledge in real time, enabling communication within and between teams and giving access to the information people need to make more effective operational decisions. AI supports continuous improvement by providing enhanced decision making. Data-driven insights help teams make faster, more informed decisions using real-time data. Streamlined knowledge sharing can happen when AI applications capture relevant knowledge, making valuable information accessible to all managers at every level of the organization. Improved collaboration occurs by consolidating data and automating communication. AI strengthens teamwork and information flow across shifts and departments. Under the umbrella of continuous improvement is consistent process optimization. AI analyzes workflow patterns and bottlenecks over time, uncovering opportunities for ongoing improvements in production quality. Data-driven problem-solving can make a significant impact on a pharmaceutical company's profitability. For instance, AI surfaces actionable insights from past experiences, enabling quicker and more effective root cause analysis and more efficient problem solving. Empowering Human-AI Collaboration For AI tools to drive continuous improvement, they need to be rooted in the practical needs and workflows of the people using them. The next progression for pharma manufacturing is Industry 5.0, which emphasizes collaboration between humans and machines. Industry 5.0 is the natural evolution from Industry 4.0, where automation and data management are partnered with human know-how. This symbiosis of humans and technologies allows humans to be the creative brain, resulting in faster and more innovative decision making. When AI tools are designed to support employees' tasks and decision making, they empower teams to work smarter, adapt faster and create a sustainable culture of continuous improvement. By pinpointing specific areas where AI can make a quick impact, like root cause analysis, predictive maintenance or knowledge management, the value can be immediate while keeping the enterprise rollout manageable. Taking the time to plan the rollout carefully, with a focus on training and creating a solid adoption plan, will make the transition smoother and encourage long-term use. The journey toward an AI-powered future in pharma requires a certain kind of strategy, one that focuses on a human-centered approach as well as provides continuous improvement. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Yahoo
17-03-2025
- Business
- Yahoo
Körber Certifies eschbach's Shiftconnector Platform for Enhanced Shopfloor Collaboration Using PAS-X MES Data
LÜNEBURG, GERMANY AND BOSTON, MA / / March 17, 2025 / Körber welcomes eschbach as the first partner in the newly established PAS-X Data Access category of the Körber Ecosystem Partner program. This partnership empowers pharmaceutical manufacturers to leverage PAS-X MES data in Shiftconnector for real-time transparency across teams and departments to increase operational efficiency and excellence. In today's fast-evolving pharmaceutical landscape, manufacturers require integrated systems that streamline production, enhance efficiency, and enable data-driven decision-making. Körber's PAS-X MES is a cornerstone of modern pharmaceutical manufacturing, ensuring precise execution of production processes while capturing critical data for batch record release, analytics, and AI-driven insights. PAS-X Data Access provides an easy way to work with PAS-X MES data for further use cases and thus supports driving the digitalization of pharma production operations forward. eschbach, headquartered in Bad Säckingen Germany, with a subsidiary in Boston, MA, brings its industry-leading Shiftconnector SaaS platform to tackle these challenges. By providing a centralized platform to monitor manufacturing status in real-time, Shiftconnector creates operational transparency and enhances collaboration among cleanroom operators, control room personnel, shift teams, quality control, and maintenance technicians. Its AI-driven capabilities accelerate access to manufacturing data and organizational knowledge, reducing inefficiencies and minimizing risk. With nearly 100,000 users globally, eschbach's Shiftconnector is a trusted solution for leading biopharma and pharmaceutical manufacturers. As a Körber Ecosystem Partner, the platform now seamlessly integrates PAS-X MES data - including production orders, downtime alerts, and deviation reporting - delivering unparalleled insights and operational improvements. "We are excited to welcome eschbach as our first PAS-X Data Access Partner," says Lars Hornung, Senior Principal Alliances & Technology Partners Software at Business Area Pharma. "The introduction of this new partnership category within Körber Partner Ecosystem, along with eschbach as our first partner, reinforces our commitment to fostering interoperable solutions. This collaboration enables manufacturers to unlock the full potential of their MES data, driving operational excellence and informed decision-making." "We are proud to be the first partner in Körber's PAS-X Data Access category. By integrating PAS-X MES data with Shiftconnector, we're unlocking new levels of transparency and efficiency. This collaboration enables pharma and biopharma enterprises to make faster, smarter decisions, driving operational excellence at every organizational level of manufacturing," adds Andreas Eschbach, Chief Executive Officer at eschbach. Andreas Eschbach, Founder & Chief Executive Officer, eschbach GmbH Lars Hornung, Senior Principal Alliances & Technology Partners Software, Körber Business Area Pharma About Eschbach With European headquarters in Bad Säckingen, Germany and U.S. headquarters in Boston, MA, eschbach is the global enterprise software developer for plant process management. Shiftconnector incorporates AI technology and helps manufacturing teams take charge of plant operations, process safety, asset performance, and product quality. eschbach serves process industries and supports digital transformation and Industry 5.0, helping managers, operators, and technicians to achieve the highest level of team communications. The award-winning solution is trusted worldwide by leading manufacturing companies such as DuPont, Albermarle, BASF, Roche, and Bayer. For more information, visit Contact US Dawn FontaineRipple Effect CommunicationsT: 617-536-8887E-mail: dawn@ About Körber We are Körber - an international technology group with more than 13,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group. At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world's leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value. Contact Dirk EbbeckeKörber Business Area PharmaHead of Product MarketingT: +49 4131 8900-0E-mail: SOURCE: eschbach View the original press release on ACCESS Newswire
Associated Press
17-03-2025
- Business
- Associated Press
Körber Certifies eschbach's Shiftconnector Platform for Enhanced Shopfloor Collaboration Using PAS-X MES Data
LÜNEBURG, GERMANY AND BOSTON, MA / ACCESS Newswire / March 17, 2025 / Körber welcomes eschbach as the first partner in the newly established PAS-X Data Access category of the Körber Ecosystem Partner program. This partnership empowers pharmaceutical manufacturers to leverage PAS-X MES data in Shiftconnector for real-time transparency across teams and departments to increase operational efficiency and excellence. In today's fast-evolving pharmaceutical landscape, manufacturers require integrated systems that streamline production, enhance efficiency, and enable data-driven decision-making. Körber's PAS-X MES is a cornerstone of modern pharmaceutical manufacturing, ensuring precise execution of production processes while capturing critical data for batch record release, analytics, and AI-driven insights. PAS-X Data Access provides an easy way to work with PAS-X MES data for further use cases and thus supports driving the digitalization of pharma production operations forward. eschbach, headquartered in Bad Säckingen Germany, with a subsidiary in Boston, MA, brings its industry-leading Shiftconnector SaaS platform to tackle these challenges. By providing a centralized platform to monitor manufacturing status in real-time, Shiftconnector creates operational transparency and enhances collaboration among cleanroom operators, control room personnel, shift teams, quality control, and maintenance technicians. Its AI-driven capabilities accelerate access to manufacturing data and organizational knowledge, reducing inefficiencies and minimizing risk. With nearly 100,000 users globally, eschbach's Shiftconnector is a trusted solution for leading biopharma and pharmaceutical manufacturers. As a Körber Ecosystem Partner, the platform now seamlessly integrates PAS-X MES data - including production orders, downtime alerts, and deviation reporting - delivering unparalleled insights and operational improvements. 'We are excited to welcome eschbach as our first PAS-X Data Access Partner,' says Lars Hornung, Senior Principal Alliances & Technology Partners Software at Business Area Pharma. 'The introduction of this new partnership category within Körber Partner Ecosystem, along with eschbach as our first partner, reinforces our commitment to fostering interoperable solutions. This collaboration enables manufacturers to unlock the full potential of their MES data, driving operational excellence and informed decision-making.' 'We are proud to be the first partner in Körber's PAS-X Data Access category. By integrating PAS-X MES data with Shiftconnector, we're unlocking new levels of transparency and efficiency. This collaboration enables pharma and biopharma enterprises to make faster, smarter decisions, driving operational excellence at every organizational level of manufacturing,' adds Andreas Eschbach, Chief Executive Officer at eschbach. Andreas Eschbach, Founder & Chief Executive Officer, eschbach GmbH Lars Hornung, Senior Principal Alliances & Technology Partners Software, Körber Business Area Pharma About Eschbach With European headquarters in Bad Säckingen, Germany and U.S. headquarters in Boston, MA, eschbach is the global enterprise software developer for plant process management. Shiftconnector incorporates AI technology and helps manufacturing teams take charge of plant operations, process safety, asset performance, and product quality. eschbach serves process industries and supports digital transformation and Industry 5.0, helping managers, operators, and technicians to achieve the highest level of team communications. The award-winning solution is trusted worldwide by leading manufacturing companies such as DuPont, Albermarle, BASF, Roche, and Bayer. For more information, visit Contact US Dawn Fontaine Ripple Effect Communications T: 617-536-8887 About Körber We are Körber - an international technology group with more than 13,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group. At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world's leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value. Contact Dirk Ebbecke T: +49 4131 8900-0
